These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30948867)

  • 1. Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC): Initial Experience from Indian Centers and a Review of Literature.
    Katdare N; Prabhu R; Mishra S; Mehta S; Bhatt A
    Indian J Surg Oncol; 2019 Mar; 10(1):24-30. PubMed ID: 30948867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pressurized intraperitoneal aerosol chemotherapy procedure for nonresectable peritoneal carcinomatosis: First Indian study.
    Somashekhar SP; Ashwin KR; Kumar CR; Rauthan A; Rakshit SH
    South Asian J Cancer; 2019; 8(1):27-30. PubMed ID: 30766848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in a French hyperthermic intraperitoneal chemotherapy (HIPEC) expert center.
    Ceribelli C; Debs T; Chevallier A; Piche MA; Bereder JM
    Surg Endosc; 2020 Jun; 34(6):2803-2806. PubMed ID: 32166545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Girshally R; Demtröder C; Albayrak N; Zieren J; Tempfer C; Reymond MA
    World J Surg Oncol; 2016 Sep; 14(1):253. PubMed ID: 27678344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unresectable peritoneal metastasis treated by pressurized intraperitoneal aerosol chemotherapy (PIPAC) leading to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
    Alyami M; Mercier F; Siebert M; Bonnot PE; Laplace N; Villeneuve L; Passot G; Glehen O; Bakrin N; Kepenekian V
    Eur J Surg Oncol; 2021 Jan; 47(1):128-133. PubMed ID: 31253545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practice patterns, attitudes, and knowledge among clinicians regarding hyperthermic intraperitoneal chemotherapy and pressurized intraperitoneal aerosol chemotherapy: a national survey by Indian society of peritoneal surface malignancies (ISPSM).
    Somashekhar SP; Rohit KC; Deo SVS; Ashwin KR
    Pleura Peritoneum; 2020 Sep; 5(3):20200120. PubMed ID: 33364340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pressurized IntraPeritoneal Aerosol Chemotherapy vs. intravenous chemotherapy for unresectable peritoneal metastases secondary to platinum resistant ovarian cancer - study protocol for a randomized control trial.
    Somashekhar SP; Ashwin KR; Rauthan A; Rohit KC
    Pleura Peritoneum; 2019 Mar; 4(1):20180111. PubMed ID: 31198851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study.
    Kepenekian V; Péron J; You B; Bonnefoy I; Villeneuve L; Alyami M; Bakrin N; Rousset P; Benzerdjeb N; Glehen O
    Ann Surg Oncol; 2022 Mar; 29(3):2104-2113. PubMed ID: 34713369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized control trial comparing quality of life of patients with end-stage peritoneal metastasis treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) and intravenous chemotherapy.
    Somashekhar SP; Ashwin KR; Rauthan CA; Rohit KC
    Pleura Peritoneum; 2018 Sep; 3(3):20180110. PubMed ID: 30911661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIPAC EstoK 01: Pressurized IntraPeritoneal Aerosol Chemotherapy with cisplatin and doxorubicin (PIPAC C/D) in gastric peritoneal metastasis: a randomized and multicenter phase II study.
    Eveno C; Jouvin I; Pocard M
    Pleura Peritoneum; 2018 Jun; 3(2):20180116. PubMed ID: 30911659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [PIPAC and HIPEC-competing or supplementary therapeutic procedures for peritoneal metastases].
    Leebmann H; Piso P
    Chirurg; 2018 Sep; 89(9):693-698. PubMed ID: 29931380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter dose-escalation Phase I trial of mitomycin C pressurized intraperitoneal aerosolized chemotherapy in combination with systemic chemotherapy for appendiceal and colorectal peritoneal metastases: rationale and design.
    Raoof M; Sullivan KM; Frankel PH; Fakih M; Synold TW; Lim D; Woo Y; Paz IB; Fong Y; Thomas RM; Chang S; Eng M; Tinsley R; Whelan RL; Deperalta D; Reymond MA; Jones J; Merchea A; Dellinger TH
    Pleura Peritoneum; 2022 Dec; 7(4):169-177. PubMed ID: 36560966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal surface malignancies (PSM): a prospective single-center registry study.
    Jansen-Winkeln B; Eberth J; Moulla Y; Mehdorn M; Niebisch S; Schierle K; Bläker H; Lordick F; Gockel I; Thieme R
    J Cancer Res Clin Oncol; 2023 Mar; 149(3):1331-1341. PubMed ID: 36513815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I/II study of oxaliplatin dose escalation via a laparoscopic approach using pressurized aerosol intraperitoneal chemotherapy (PIPOX trial) for nonresectable peritoneal metastases of digestive cancers (stomach, small bowel and colorectal): Rationale and design.
    Dumont F; Senellart H; Pein F; Campion L; Glehen O; Goere D; Pocard M; Thibaudeau E
    Pleura Peritoneum; 2018 Sep; 3(3):20180120. PubMed ID: 30911664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in multimodal therapy for patients with oligometastatic peritoneal gastric cancer: a randomized multicenter phase III trial PIPAC VEROne.
    Casella F; Bencivenga M; Rosati R; Fumagalli UR; Marrelli D; Pacelli F; Macrì A; Donini A; Torroni L; Pavarana M; De Manzoni G
    Pleura Peritoneum; 2022 Sep; 7(3):135-141. PubMed ID: 36159218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Perioperative safety of intraperitoneal aerosol chemotherapy : Analysis of our first 111 pressurized intraperitoneal aerosol chemotherapy (PIPAC) procedures].
    Jansen-Winkeln B; Thieme R; Haase L; Niebisch S; Pommer C; Lyros O; Zimmer J; Lordick F; Remane Y; Frontini R; Gockel I
    Chirurg; 2019 Feb; 90(2):137-145. PubMed ID: 29947920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in combination with standard of care chemotherapy in primarily untreated chemo naïve upper gi-adenocarcinomas with peritoneal seeding - a phase II/III trial of the AIO/CAOGI/ACO.
    Oliver Goetze T; Al-Batran SE; Pabst U; Reymond M; Tempfer C; Bechstein WO; Bankstahl U; Gockel I; Königsrainer A; Kraus T; Mönig SP; Rau B; Schwarzbach M; Piso P
    Pleura Peritoneum; 2018 Jun; 3(2):20180113. PubMed ID: 30911658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A bidirectional approach for gastric cancer peritoneal metastasis.
    Di Giorgio A; Schena CA; El Halabieh MA; Abatini C; Vita E; Strippoli A; Inzani F; Rodolfino E; Romanò B; Pacelli F; Rotolo S
    Surg Oncol; 2020 Sep; 34():270-275. PubMed ID: 32891341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and feasibility of pressurized intraperitoneal aerosol chemotherapy (PIPAC) associated with systemic chemotherapy: an innovative approach to treat peritoneal carcinomatosis.
    Robella M; Vaira M; De Simone M
    World J Surg Oncol; 2016 Apr; 14():128. PubMed ID: 27125996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emergence of pressurized intraperitoneal aerosol chemotherapy as a palliative treatment option for patients with diffuse peritoneal metastases: a narrative review.
    Lurvink RJ; Van der Speeten K; Rovers KP; de Hingh IHJT
    J Gastrointest Oncol; 2021 Apr; 12(Suppl 1):S259-S270. PubMed ID: 33968442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.